Trial intelligence / Profile preview

Torcetrapib/Atorvastatin in Type IV Hypertriglyceridemia

NCT00134498Phase 3Completed

Sponsor
Pfizer
Start
Feb 2005
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of torcetrapib in hypertriglyceridemia, sponsored by Pfizer. Started Feb 2005; status: completed.

02

Drugs

torcetrapib
03

Conditions

hypertriglyceridemia

Beyond the preview

Go deeper on NCT00134498.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00134498.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call